Safety of DOACs in patients with Child‐Pugh Class C cirrhosis and atrial fibrillation
Abstract Background Anticoagulation (AC) is used for stroke prevention in atrial fibrillation (AF). Direct Oral Anticoagulants (DOACs) are safe in patients with AF without cirrhosis, they are hardly studied in patients with advanced cirrhosis. Our study evaluates the safety and outcomes of DOACs in...
Saved in:
| Main Authors: | Mark Ayoub, Carol Faris, Julton Tomanguillo Chumbe, Ebubekir Daglilar, Nadeem Anwar, Vishnu Naravadi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-05-01
|
| Series: | JGH Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.13074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy
by: N. V. Bakulina, et al.
Published: (2021-09-01) -
Hemostasis system correction in patients with cirrhosis
by: А. S. Tugushev, et al.
Published: (2015-10-01) -
HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01) -
Outpatient use of antibiotics in uncomplicated diverticulitis decreases hospital admissions
by: Mark Ayoub, et al.
Published: (2024-09-01) -
Diagnosis and Management of Portal Vein Thrombosis in Liver Cirrhosis
by: Cynthia Kurniawan, et al.
Published: (2025-04-01)